185 related articles for article (PubMed ID: 28456498)
1. Fibroblast growth factor-23 is independently associated with cardiac mass in African-American adolescent males.
Falkner B; Keith SW; Gidding SS; Langman CB
J Am Soc Hypertens; 2017 Aug; 11(8):480-487. PubMed ID: 28456498
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor-23 in obese, normotensive adolescents is associated with adverse cardiac structure.
Ali FN; Falkner B; Gidding SS; Price HE; Keith SW; Langman CB
J Pediatr; 2014 Oct; 165(4):738-43.e1. PubMed ID: 25063724
[TBL] [Abstract][Full Text] [Related]
3. FGF23 and Left Ventricular Hypertrophy in Children with CKD.
Mitsnefes MM; Betoko A; Schneider MF; Salusky IB; Wolf MS; Jüppner H; Warady BA; Furth SL; Portale AA
Clin J Am Soc Nephrol; 2018 Jan; 13(1):45-52. PubMed ID: 29025789
[TBL] [Abstract][Full Text] [Related]
4. Relationship of FGF23 to indexed left ventricular mass in children with non-dialysis stages of chronic kidney disease.
Sinha MD; Turner C; Booth CJ; Waller S; Rasmussen P; Goldsmith DJ; Simpson JM
Pediatr Nephrol; 2015 Oct; 30(10):1843-52. PubMed ID: 25975437
[TBL] [Abstract][Full Text] [Related]
5. Ghrelin PYY 3-36 serum changes in left ventricular hypertrophic, insulin-resistant, hypertensive obese patients.
Karcz-Socha I; Zwirska-Korczala K; Zembala M; Borgiel-Marek H; Karcz K
Obes Facts; 2011; 4(5):386-92. PubMed ID: 22166759
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor 23 is associated with left ventricular hypertrophy, not with uremic vasculopathy in peritoneal dialysis patients.
Sarmento-Dias M; Santos-Araújo C; Poínhos R; Oliveira B; Silva IS; Silva LS; Sousa MJ; Correia F; Pestana M
Clin Nephrol; 2016 Mar; 85(3):135-41. PubMed ID: 26833300
[TBL] [Abstract][Full Text] [Related]
7. High risk blood pressure and obesity increase the risk for left ventricular hypertrophy in African-American adolescents.
Falkner B; DeLoach S; Keith SW; Gidding SS
J Pediatr; 2013 Jan; 162(1):94-100. PubMed ID: 22817908
[TBL] [Abstract][Full Text] [Related]
8. Association between plasma fibroblast growth factor 23 and left ventricular mass index in patients with Takayasu arteritis.
Cheng N; He Y; Dang A; Lv N; Wang X; Li H
Clin Rheumatol; 2020 May; 39(5):1591-1599. PubMed ID: 31897962
[TBL] [Abstract][Full Text] [Related]
9. FGF23 in hemodialysis patients is associated with left ventricular hypertrophy and reduced ejection fraction.
Nielsen TL; Plesner LL; Warming PE; Mortensen OH; Iversen KK; Heaf JG
Nefrologia (Engl Ed); 2019; 39(3):258-268. PubMed ID: 30723045
[TBL] [Abstract][Full Text] [Related]
10. The association between obesity, hypertension and left ventricular mass in adolescents.
Dibeklioglu SE; Çevik BŞ; Acar B; Özçakar ZB; Uncu N; Kara N; Çaycı Ş; Çakar N
J Pediatr Endocrinol Metab; 2017 Feb; 30(2):167-174. PubMed ID: 28099129
[TBL] [Abstract][Full Text] [Related]
11. The relationship between blood pressure and left ventricular mass index depends on an excess adiposity.
Norton GR; Majane OH; Libhaber E; Maseko MJ; Makaula S; Libhaber C; Woodiwiss AJ
J Hypertens; 2009 Sep; 27(9):1873-83. PubMed ID: 19512944
[TBL] [Abstract][Full Text] [Related]
12. Plasma C-terminal pro-endothelin-1 is associated with left ventricular mass index and aortic root diameter in African-American adults with hypertension.
Al-Omari MA; Khaleghi M; Mosley TH; Morgenthaler NG; Struck J; Bergmann A; Kullo IJ
J Hum Hypertens; 2011 Feb; 25(2):106-13. PubMed ID: 20182452
[TBL] [Abstract][Full Text] [Related]
13. Correlation between hypervolemia, left ventricular hypertrophy and fibroblast growth factor 23 in hemodialysis patients.
Unver S; Kavlak E; Gümüsel HK; Celikbilek F; Esertas K; Muftuoglu T; Kirilmaz A
Ren Fail; 2015 Jul; 37(6):951-6. PubMed ID: 26030798
[TBL] [Abstract][Full Text] [Related]
14. Childhood obesity increases left-ventricular mass irrespective of blood pressure status.
Kharod AM; Ramlogan SR; Kumar S; Raghuveer T; Drake W; Dai H; Raghuveer G
Pediatr Cardiol; 2014 Feb; 35(2):353-60. PubMed ID: 23989657
[TBL] [Abstract][Full Text] [Related]
15. Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population.
Mirza MA; Larsson A; Melhus H; Lind L; Larsson TE
Atherosclerosis; 2009 Dec; 207(2):546-51. PubMed ID: 19524924
[TBL] [Abstract][Full Text] [Related]
16. Is there a relationship between left ventricular mass and plasma glucose and lipids independent of body mass index? Results of the Gubbio Study.
Ferrara AL; Vaccaro O; Cardoni O; Panarelli W; Laurenzi M; Zanchetti A
Nutr Metab Cardiovasc Dis; 2003 Jun; 13(3):126-32. PubMed ID: 12955793
[TBL] [Abstract][Full Text] [Related]
17. Association Between Elevated Body Mass Index and Cardiac Organ Damage in Children and Adolescents: Evidence and Mechanisms.
Annaloro A; Invernizzi C; Aguilar F; Alvarez J; Cuspidi C; Grassi G; Lurbe E
High Blood Press Cardiovasc Prev; 2024 Mar; 31(2):167-175. PubMed ID: 38530573
[TBL] [Abstract][Full Text] [Related]
18. The role of blood pressure, body weight and fat distribution on left ventricular mass, diastolic function and cardiac geometry in children.
Pieruzzi F; Antolini L; Salerno FR; Giussani M; Brambilla P; Galbiati S; Mastriani S; Rebora P; Stella A; Valsecchi MG; Genovesi S
J Hypertens; 2015 Jun; 33(6):1182-92. PubMed ID: 25715095
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor 23, left ventricular mass, and left ventricular hypertrophy in community-dwelling older adults.
Jovanovich A; Ix JH; Gottdiener J; McFann K; Katz R; Kestenbaum B; de Boer IH; Sarnak M; Shlipak MG; Mukamal KJ; Siscovick D; Chonchol M
Atherosclerosis; 2013 Nov; 231(1):114-9. PubMed ID: 24125420
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance syndrome and left ventricular mass in healthy young people.
Davis CL; Kapuku G; Snieder H; Kumar M; Treiber FA
Am J Med Sci; 2002 Aug; 324(2):72-5. PubMed ID: 12186110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]